This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

€500 savings end in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
THE SPRINGTIME PARTNERING EVENT
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

Immunofusion

Profile

Immunofusion is a privately funded biotech established in 2019 by antibody engineering and Cell\DNA-therapy experts. Our academic background includes CAR T-cell and DNA-vaccine development from bench to bedside and the proprietary extra-large humanized nanobody library that yields specific and high affinity binders. We are focused on the development of two platforms - CAR T-cell therapy for the unment medical needs in CLL and MCL and DNA-encoded immunocytokines for the treatment of solid tumors.